173 related articles for article (PubMed ID: 34843121)
1. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
2. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
[TBL] [Abstract][Full Text] [Related]
4. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
5. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
Qi L; Chen Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):251-270. PubMed ID: 36374935
[TBL] [Abstract][Full Text] [Related]
6. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
8. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
10. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
[TBL] [Abstract][Full Text] [Related]
11. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.
Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
J Intern Med; 2018 Nov; 284(5):546-559. PubMed ID: 29964306
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
[TBL] [Abstract][Full Text] [Related]
13. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
Mercer KE; Maurer A; Pack LM; Ono-Moore K; Spray BJ; Campbell C; Chandler CJ; Burnett D; Souza E; Casazza G; Keim N; Newman J; Hunter G; Fernadez J; Garvey WT; Harper ME; Hoppel C; Adams SH; Thyfault J
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E864-E873. PubMed ID: 33645254
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
Lukanova A; Becker S; Hüsing A; Schock H; Fedirko V; Trepo E; Trichopoulou A; Bamia C; Lagiou P; Benetou V; Trichopoulos D; Nöthlings U; Tjønneland A; Overvad K; Dossus L; Teucher B; Boeing H; Aleksandrova K; Palli D; Pala V; Panico S; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Quiros JR; Duell EJ; Molina-Montes E; Chirlaque MD; Gurrea AB; Dorronsoro M; Lindkvist B; Johansen D; Werner M; Sund M; Khaw KT; Wareham N; Key TJ; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Jenab M; Kaaks R
Int J Cancer; 2014 Jan; 134(1):164-73. PubMed ID: 23801371
[TBL] [Abstract][Full Text] [Related]
15. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
Song Y; Lau HC; Zhang X; Yu J
Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bile acids profiles in the enterohepatic circulation system of mice and rats.
Duan Z; Yang T; Li L; Wang X; Wei C; Xia Z; Chai Y; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2022 Jun; 220():106100. PubMed ID: 35341917
[TBL] [Abstract][Full Text] [Related]
17. Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries.
Wei M; Shao Y; Liu QR; Wu QZ; Zhang X; Zhong MW; Liu SZ; Zhang GY; Hu SY
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G537-G546. PubMed ID: 29351394
[TBL] [Abstract][Full Text] [Related]
18. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice.
Csanaky IL; Aleksunes LM; Tanaka Y; Klaassen CD
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G419-33. PubMed ID: 19497955
[TBL] [Abstract][Full Text] [Related]
20. Growth performance, bile acid profile, fecal microbiome and serum metabolomics of growing-finishing pigs fed diets with bile acids supplementation.
Zhou P; Yan H; Zhang Y; Qi R; Zhang H; Liu J
J Anim Sci; 2023 Jan; 101():. PubMed ID: 38006392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
